The new prices were made possible by the Medicare negotiation program created under the Biden administration's Inflation ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

New research suggests that drugs like Ozempic and Wegovy might trigger more than just a slimmer waistline. Many users have ...

As Trump takes a victory lap on lower drug prices, he should thank Biden for signing a key law that made it possible.

The Trump administration’s negotiation with Novo Nordisk A/S that slashes 71% off the list price of its blockbusters Ozempic ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

PFE's oncology gains and obesity re-entry contrast with NVO's GLP-1 pressures in this in-depth comparison of two healthcare ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, Novo Nordisk said.

The federal government says it has struck a deal to dramatically lower prices on 15 widely used medications covered by ...

The Trump administration has announced new, lower Medicare prices for 15 drugs, including Ozempic, Wegovy, and key cancer treatments, effective in 2027.

Next-generation weight loss pills are expected to hit the market next year, and drugmakers are working on medications with ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...